- Home
- BKSY vs JANX Comparison
BKSY vs JANX Comparison
Compare BKSY & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKSY | JANX |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 839.0M | 975.7M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BKSY | JANX |
|---|---|---|
| Price | $23.05 | $16.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | $28.50 | ★ $47.00 |
| AVG Volume (30 Days) | 771.4K | ★ 817.5K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.72 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $10,000,000.00 |
| Revenue This Year | $27.03 | N/A |
| Revenue Next Year | $29.21 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.41 | $12.12 |
| 52 Week High | $52.88 | $35.34 |
Technical Indicators
Market Signals| Indicator | BKSY | JANX |
|---|---|---|
| Relative Strength Index (RSI) | 39.08 | 39.06 |
| Support Level | $20.50 | $15.61 |
| Resistance Level | $24.35 | $16.68 |
| Average True Range (ATR) | 1.25 | 0.78 |
| MACD | -0.11 | -0.42 |
| Stochastic Oscillator | 22.74 | 0.74 |
Price Performance
Historical ComparisonAbout BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a space-based technology company that delivers real-time imagery, analytics and high-frequency monitoring of the worlds critical and strategic locations, economic assets, and events. By taking a software-first technology approach, Company is delivering real-time space-based intelligence at disruptive speed, scale and economics. Companies single operating and reportable segment, provided space-based intelligence products and services through three integrated revenue streams-space-based intelligence & AI services, mission solutions, and technology programs. Geographically, the company operates in United States and Rest of world.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.